posted on 2025-06-06, 09:46authored bySN Ladhani, F Aiano, DS Edwards, S Perkins, WM Khan, N Iyanger, E Whittaker, JM Cohen, D Ho, S Hopkins, ME Ramsay, JY Chow
We investigated a secondary school (11–16 year-olds), a primary school (5–11 year-olds), reception year (4–5 year-olds) and a nursery (2–5 year-olds) following confirmed monkeypox in an adult in each educational setting during June and July 2022. MVA-BN vaccine was offered up to 14 days post exposure to 186 children < 12 years and 21 were vaccinated. No secondary cases occurred among at least 340 exposed students and more than 100 exposed staff during the 28-day followup period.
History
Publication status
Published
File Version
Published version
Journal
Eurosurveillance
ISSN
1025-496X
Publisher
European Centre for Disease Control and Prevention (ECDC)